位置:首页 > 蛋白库 > R1A_IBVB
R1A_IBVB
ID   R1A_IBVB                Reviewed;        3951 AA.
AC   P0C6V3; P27920;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   10-JUN-2008, sequence version 1.
DT   03-AUG-2022, entry version 77.
DE   RecName: Full=Replicase polyprotein 1a;
DE            Short=pp1a;
DE   AltName: Full=ORF1a polyprotein;
DE   Contains:
DE     RecName: Full=Non-structural protein 2;
DE              Short=nsp2;
DE     AltName: Full=p87;
DE   Contains:
DE     RecName: Full=Papain-like protease;
DE              Short=PL-PRO;
DE              EC=3.4.19.12 {ECO:0000250|UniProtKB:P0C6U8};
DE              EC=3.4.22.- {ECO:0000250|UniProtKB:P0C6U8};
DE     AltName: Full=Non-structural protein 3;
DE              Short=nsp3;
DE     AltName: Full=p195;
DE   Contains:
DE     RecName: Full=Non-structural protein 4;
DE              Short=nsp4;
DE     AltName: Full=Peptide HD2;
DE     AltName: Full=p41;
DE   Contains:
DE     RecName: Full=3C-like proteinase;
DE              Short=3CL-PRO;
DE              Short=3CLp;
DE              EC=3.4.22.-;
DE     AltName: Full=Main protease;
DE              Short=Mpro;
DE     AltName: Full=Non-structural protein 5;
DE              Short=nsp5;
DE     AltName: Full=p33;
DE   Contains:
DE     RecName: Full=Non-structural protein 6;
DE              Short=nsp6;
DE     AltName: Full=p34;
DE   Contains:
DE     RecName: Full=Non-structural protein 7;
DE              Short=nsp7;
DE     AltName: Full=p9;
DE   Contains:
DE     RecName: Full=Non-structural protein 8;
DE              Short=nsp8;
DE     AltName: Full=p24;
DE   Contains:
DE     RecName: Full=Non-structural protein 9;
DE              Short=nsp9;
DE     AltName: Full=p10;
DE   Contains:
DE     RecName: Full=Non-structural protein 10;
DE              Short=nsp10;
DE     AltName: Full=Growth factor-like peptide;
DE              Short=GFL;
DE     AltName: Full=p16;
DE   Contains:
DE     RecName: Full=Non-structural protein 11;
DE              Short=nsp11;
GN   ORFNames=1a;
OS   Avian infectious bronchitis virus (strain Beaudette) (IBV).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Gammacoronavirus; Igacovirus.
OX   NCBI_TaxID=11122;
OH   NCBI_TaxID=9031; Gallus gallus (Chicken).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=3027249; DOI=10.1099/0022-1317-68-1-57;
RA   Boursnell M.E.G., Brown T.D.K., Foulds I.J., Green P.F., Tomley F.M.,
RA   Binns M.M.;
RT   "Completion of the sequence of the genome of the coronavirus avian
RT   infectious bronchitis virus.";
RL   J. Gen. Virol. 68:57-77(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Isolate Vero cell-adapted p65;
RX   PubMed=16137658; DOI=10.1016/j.bbrc.2005.08.105;
RA   Fang S.G., Shen S., Tay F.P., Liu D.X.;
RT   "Selection of and recombination between minor variants lead to the
RT   adaptation of an avian coronavirus to primate cells.";
RL   Biochem. Biophys. Res. Commun. 336:417-423(2005).
RN   [3]
RP   PROTEOLYTIC CLEAVAGE (REPLICASE POLYPROTEIN 1A).
RX   PubMed=11831730; DOI=10.1006/viro.1995.1128;
RA   Liu D.X., Tibbles K.W., Cavanagh D., Brown T.D.K., Brierley I.;
RT   "Identification, expression, and processing of an 87-kDa polypeptide
RT   encoded by ORF 1a of the coronavirus infectious bronchitis virus.";
RL   Virology 208:48-57(1995).
RN   [4]
RP   CHARACTERIZATION OF 3CL-PRO, AND MUTAGENESIS OF HIS-2820; GLU-2841;
RP   GLU-2843; CYS-2922 AND GLN-3928.
RX   PubMed=7778277; DOI=10.1006/viro.1995.1274;
RA   Liu D.X., Brown T.D.K.;
RT   "Characterisation and mutational analysis of an ORF 1a-encoding proteinase
RT   domain responsible for proteolytic processing of the infectious bronchitis
RT   virus 1a/1b polyprotein.";
RL   Virology 209:420-427(1995).
RN   [5]
RP   PROTEOLYTIC CLEAVAGE (REPLICASE POLYPROTEIN 1A), AND MUTAGENESIS OF
RP   GLN-3672 AND GLN-3783.
RX   PubMed=9032311; DOI=10.1128/jvi.71.3.1814-1820.1997;
RA   Liu D.X., Xu H.Y., Brown T.D.K.;
RT   "Proteolytic processing of the coronavirus infectious bronchitis virus 1a
RT   polyprotein: identification of a 10-kilodalton polypeptide and
RT   determination of its cleavage sites.";
RL   J. Virol. 71:1814-1820(1997).
RN   [6]
RP   PROTEOLYTIC CLEAVAGE (REPLICASE POLYPROTEIN 1A), AND MUTAGENESIS OF
RP   GLN-3462; GLN-3672 AND GLN-3783.
RX   PubMed=9568037; DOI=10.1006/viro.1998.9058;
RA   Ng L.F.P., Liu D.X.;
RT   "Identification of a 24-kDa polypeptide processed from the coronavirus
RT   infectious bronchitis virus 1a polyprotein by the 3C-like proteinase and
RT   determination of its cleavage sites.";
RL   Virology 243:388-395(1998).
RN   [7]
RP   PROTEOLYTIC CLEAVAGE (REPLICASE POLYPROTEIN 1A), CHARACTERIZATION OF
RP   PAPAIN-LIKE PROTEINASE DOMAINS, AND MUTAGENESIS OF GLY-673; THR-676;
RP   CYS-1274 AND HIS-1437.
RX   PubMed=9636369; DOI=10.1006/viro.1998.9164;
RA   Lim K.P., Liu D.X.;
RT   "Characterization of the two overlapping papain-like proteinase domains
RT   encoded in gene 1 of the coronavirus infectious bronchitis virus and
RT   determination of the C-terminal cleavage site of an 87-kDa protein.";
RL   Virology 245:303-312(1998).
RN   [8]
RP   PROTEOLYTIC CLEAVAGE (REPLICASE POLYPROTEIN 1A).
RX   PubMed=9657947; DOI=10.1006/viro.1998.9199;
RA   Liu D.X., Shen S., Xu H.Y., Wang S.F.;
RT   "Proteolytic mapping of the coronavirus infectious bronchitis virus 1b
RT   polyprotein: evidence for the presence of four cleavage sites of the 3C-
RT   like proteinase and identification of two novel cleavage products.";
RL   Virology 246:288-297(1998).
RN   [9]
RP   PROTEOLYTIC CLEAVAGE (REPLICASE POLYPROTEIN 1A), GLYCOSYLATION OF NSP4, AND
RP   MUTAGENESIS OF ALA-2264; GLY-2265 AND GLY-2266.
RX   PubMed=10644337; DOI=10.1128/jvi.74.4.1674-1685.2000;
RA   Lim K.P., Ng L.F.P., Liu D.X.;
RT   "Identification of a novel cleavage activity of the first papain-like
RT   proteinase domain encoded by open reading frame 1a of the coronavirus avian
RT   infectious bronchitis virus and characterization of the cleavage
RT   products.";
RL   J. Virol. 74:1674-1685(2000).
RN   [10]
RP   PROTEOLYTIC CLEAVAGE (REPLICASE POLYPROTEIN 1A), AND MUTAGENESIS OF
RP   GLN-3086; GLN-3365 AND GLN-3379.
RX   PubMed=10873746; DOI=10.1006/viro.2000.0330;
RA   Ng L.F.P., Liu D.X.;
RT   "Further characterization of the coronavirus infectious bronchitis virus
RT   3C-like proteinase and determination of a new cleavage site.";
RL   Virology 272:27-39(2000).
RN   [11]
RP   PROTEOLYTIC CLEAVAGE (REPLICASE POLYPROTEIN 1A), AND SUBCELLULAR LOCATION.
RX   PubMed=11601893; DOI=10.1006/viro.2001.1098;
RA   Xu H.Y., Lim K.P., Shen S., Liu D.X.;
RT   "Further identification and characterization of novel intermediate and
RT   mature cleavage products released from the ORF 1b region of the avian
RT   coronavirus infectious bronchitis virus 1a/1b polyprotein.";
RL   Virology 288:212-222(2001).
RN   [12]
RP   CHARACTERIZATION (NON-STRUCTURAL PROTEIN 10), AND MUTAGENESIS.
RX   PubMed=12021359; DOI=10.1128/jvi.76.12.6257-6267.2002;
RA   Ng L.F.P., Liu D.X.;
RT   "Membrane association and dimerization of a cysteine-rich, 16-kilodalton
RT   polypeptide released from the C-terminal region of the coronavirus
RT   infectious bronchitis virus 1a polyprotein.";
RL   J. Virol. 76:6257-6267(2002).
CC   -!- FUNCTION: [Isoform Replicase polyprotein 1a]: Multifunctional protein
CC       involved in the transcription and replication of viral RNAs. Contains
CC       the proteinases responsible for the cleavages of the polyprotein.
CC       {ECO:0000305}.
CC   -!- FUNCTION: [Non-structural protein 2]: May play a role in the modulation
CC       of host cell survival signaling pathway by interacting with host PHB
CC       and PHB2 (By similarity). Indeed, these two proteins play a role in
CC       maintaining the functional integrity of the mitochondria and protecting
CC       cells from various stresses (By similarity).
CC       {ECO:0000250|UniProtKB:P0C6U8}.
CC   -!- FUNCTION: [Papain-like protease]: Responsible for the cleavages located
CC       at the N-terminus of the replicase polyprotein (By similarity). In
CC       addition, PL-PRO possesses a deubiquitinating/deISGylating activity and
CC       processes both 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from
CC       cellular substrates (By similarity). {ECO:0000250|UniProtKB:P0C6U8}.
CC   -!- FUNCTION: [Non-structural protein 4]: Plays a role in host membrane
CC       rearrangement that leads to creation of cytoplasmic double-membrane
CC       vesicles (DMV) necessary for viral replication (By similarity). Alone
CC       is able to induce paired membranes (By similarity). Coexpression of
CC       nsp3 and nsp4 does not result in the formation of DMVs (By similarity).
CC       {ECO:0000250|UniProtKB:P0C6U8}.
CC   -!- FUNCTION: [3C-like proteinase]: Responsible for the majority of
CC       cleavages as it cleaves the C-terminus of replicase polyprotein at 11
CC       sites. Recognizes substrates containing the core sequence [ILMVF]-Q-|-
CC       [SGACN]. Inhibited by the substrate-analog Cbz-Val-Asn-Ser-Thr-Leu-Gln-
CC       CMK. {ECO:0000255|PROSITE-ProRule:PRU00772}.
CC   -!- FUNCTION: [Non-structural protein 7]: Forms a hexadecamer with nsp8 (8
CC       subunits of each) that may participate in viral replication by acting
CC       as a primase. Alternatively, may synthesize substantially longer
CC       products than oligonucleotide primers. {ECO:0000250|UniProtKB:P0C6U8}.
CC   -!- FUNCTION: [Non-structural protein 8]: Forms a hexadecamer with nsp7 (8
CC       subunits of each) that may participate in viral replication by acting
CC       as a primase. Alternatively, may synthesize substantially longer
CC       products than oligonucleotide primers. {ECO:0000250|UniProtKB:P0C6U8}.
CC   -!- FUNCTION: [Non-structural protein 9]: Plays an essential role in viral
CC       replication by forming a homodimer that binds single-stranded RNA.
CC       {ECO:0000250|UniProtKB:P0C6U8}.
CC   -!- FUNCTION: [Non-structural protein 10]: Plays a pivotal role in viral
CC       transcription by stimulating both nsp14 3'-5' exoribonuclease and nsp16
CC       2'-O-methyltransferase activities (By similarity). Therefore plays an
CC       essential role in viral mRNAs cap methylation (By similarity).
CC       {ECO:0000250|UniProtKB:P0C6U8}.
CC   -!- CATALYTIC ACTIVITY: [Papain-like protease]:
CC       Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide
CC         and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-
CC         residue protein attached to proteins as an intracellular targeting
CC         signal).; EC=3.4.19.12; Evidence={ECO:0000250|UniProtKB:P0C6U8};
CC   -!- COFACTOR: [Papain-like protease]:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:P0C6U8};
CC   -!- SUBUNIT: [Non-structural protein 2]: Interacts with host PHB and PHB2.
CC       {ECO:0000250|UniProtKB:P0C6U8}.
CC   -!- SUBUNIT: [Non-structural protein 4]: Interacts with papain-like
CC       protease and non-structural protein 6. {ECO:0000250|UniProtKB:P0C6U8}.
CC   -!- SUBUNIT: [3C-like proteinase]: Monomer. Homodimer. Only the homodimer
CC       shows catalytic activity. {ECO:0000250|UniProtKB:P0C6U8}.
CC   -!- SUBUNIT: [Non-structural protein 7]: Eight copies of nsp7 and eight
CC       copies of nsp8 assemble to form a heterohexadecamer dsRNA-encircling
CC       ring structure. {ECO:0000250|UniProtKB:P0C6U8}.
CC   -!- SUBUNIT: [Non-structural protein 8]: Eight copies of nsp7 and eight
CC       copies of nsp8 assemble to form a heterohexadecamer dsRNA-encircling
CC       ring structure (By similarity). Interacts with ORF6 protein (By
CC       similarity). {ECO:0000250|UniProtKB:P0C6U8}.
CC   -!- SUBUNIT: [Non-structural protein 9]: Homodimer.
CC       {ECO:0000250|UniProtKB:P0C6U8}.
CC   -!- SUBUNIT: [Non-structural protein 10]: Homododecamer.
CC       {ECO:0000250|UniProtKB:P0C6U8}.
CC   -!- INTERACTION:
CC       PRO_0000338322; PRO_0000338322 [P0C6V3]: 1a; NbExp=3; IntAct=EBI-25618172, EBI-25618172;
CC   -!- SUBCELLULAR LOCATION: [Papain-like protease]: Host endoplasmic
CC       reticulum membrane {ECO:0000250|UniProtKB:P0C6Y3}; Multi-pass membrane
CC       protein {ECO:0000305}. Host cytoplasm {ECO:0000250|UniProtKB:P0C6U8}.
CC       Note=Gammacoronaviruses induce membrane zippering to form zippered
CC       endoplasmic reticulum (zER). {ECO:0000250|UniProtKB:P0C6Y3}.
CC   -!- SUBCELLULAR LOCATION: [Non-structural protein 4]: Host endoplasmic
CC       reticulum membrane {ECO:0000250|UniProtKB:P0C6Y3}; Multi-pass membrane
CC       protein {ECO:0000305}. Host cytoplasm {ECO:0000250|UniProtKB:P0C6U8}.
CC       Note=Localizes in virally-induced cytoplasmic double-membrane vesicles
CC       (By similarity). Gammacoronaviruses induce membrane zippering to form
CC       zippered endoplasmic reticulum (zER) (By similarity).
CC       {ECO:0000250|UniProtKB:P0C6U8, ECO:0000250|UniProtKB:P0C6Y3}.
CC   -!- SUBCELLULAR LOCATION: [Non-structural protein 6]: Host endoplasmic
CC       reticulum membrane {ECO:0000250|UniProtKB:P0C6Y3}; Multi-pass membrane
CC       protein {ECO:0000305}. Note=Gammacoronaviruses induce membrane
CC       zippering to form zippered endoplasmic reticulum (zER).
CC       {ECO:0000250|UniProtKB:P0C6Y3}.
CC   -!- SUBCELLULAR LOCATION: [Non-structural protein 7]: Host cytoplasm, host
CC       perinuclear region {ECO:0000250}. Host cytoplasm
CC       {ECO:0000250|UniProtKB:P0DTD1}. Host endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:P0DTD1}. Note=nsp7, nsp8, nsp9 and nsp10 are
CC       localized in cytoplasmic foci, largely perinuclear. Late in infection,
CC       they merge into confluent complexes.
CC   -!- SUBCELLULAR LOCATION: [Non-structural protein 8]: Host cytoplasm, host
CC       perinuclear region {ECO:0000250|UniProtKB:P0C6U8}. Host cytoplasm
CC       {ECO:0000250|UniProtKB:P0DTD1}. Host endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:P0DTD1}. Note=nsp7, nsp8, nsp9 and nsp10 are
CC       localized in cytoplasmic foci, largely perinuclear. Late in infection,
CC       they merge into confluent complexes.
CC   -!- SUBCELLULAR LOCATION: [Non-structural protein 9]: Host cytoplasm, host
CC       perinuclear region {ECO:0000250}. Host cytoplasm
CC       {ECO:0000250|UniProtKB:P0DTD1}. Host endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:P0DTD1}. Note=nsp7, nsp8, nsp9 and nsp10 are
CC       localized in cytoplasmic foci, largely perinuclear. Late in infection,
CC       they merge into confluent complexes.
CC   -!- SUBCELLULAR LOCATION: [Non-structural protein 10]: Host cytoplasm, host
CC       perinuclear region {ECO:0000250}. Host cytoplasm
CC       {ECO:0000250|UniProtKB:P0DTD1}. Host endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:P0DTD1}. Note=nsp7, nsp8, nsp9 and nsp10 are
CC       localized in cytoplasmic foci, largely perinuclear. Late in infection,
CC       they merge into confluent complexes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Ribosomal frameshifting; Named isoforms=2;
CC         Comment=Isoform Replicase polyprotein 1ab is produced by -1 ribosomal
CC         frameshifting at the 1a-1b genes boundary. Isoform Replicase
CC         polyprotein 1a is produced by conventional translation.
CC         {ECO:0000305};
CC       Name=Replicase polyprotein 1a; Synonyms=pp1a, ORF1a polyprotein;
CC         IsoId=P0C6V3-1; Sequence=Displayed;
CC       Name=Replicase polyprotein 1ab; Synonyms=pp1ab;
CC         IsoId=P0C6Y1-1; Sequence=External;
CC   -!- DOMAIN: [Papain-like protease]: The hydrophobic region HD1 probably
CC       mediates the membrane association of the replication complex.
CC       {ECO:0000250|UniProtKB:P0C6U8}.
CC   -!- DOMAIN: [Non-structural protein 4]: The hydrophobic region HD2 probably
CC       mediates the membrane association of the replication complex.
CC       {ECO:0000250|UniProtKB:P0C6U8}.
CC   -!- DOMAIN: [Non-structural protein 6]: The hydrophobic region HD3 probably
CC       mediates the membrane association of the replication complex.
CC       {ECO:0000250|UniProtKB:P0C6U8}.
CC   -!- PTM: [Isoform Replicase polyprotein 1a]: Specific enzymatic cleavages
CC       in vivo by its own proteases yield mature proteins (By similarity). 3C-
CC       like proteinase nsp5 liberates nsps 6-16 from the polyprotein (By
CC       similarity). Papain-like and 3C-like proteinases are autocatalytically
CC       processed. {ECO:0000250|UniProtKB:P0C6U8}.
CC   -!- PTM: [Non-structural protein 4]: N-glycosylated.
CC       {ECO:0000250|UniProtKB:P0C6Y1}.
CC   -!- SIMILARITY: Belongs to the coronaviruses polyprotein 1ab family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M94356; AAA46223.1; -; Genomic_RNA.
DR   EMBL; M95169; AAA70233.1; -; Genomic_RNA.
DR   EMBL; DQ001339; AAY24431.1; -; Genomic_RNA.
DR   PIR; A33094; VFIHB1.
DR   PIR; B33094; VFIHB2.
DR   RefSeq; NP_040829.1; NC_001451.1.
DR   SMR; P0C6V3; -.
DR   MEROPS; C16.005; -.
DR   MEROPS; C30.002; -.
DR   PRIDE; P0C6V3; -.
DR   GeneID; 1489740; -.
DR   BRENDA; 3.4.22.B14; 8728.
DR   SABIO-RK; P0C6V3; -.
DR   Proteomes; UP000006717; Genome.
DR   GO; GO:0044167; C:host cell endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0044220; C:host cell perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0008242; F:omega peptidase activity; IEA:InterPro.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0016740; F:transferase activity; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0039520; P:induction by virus of host autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0019079; P:viral genome replication; IEA:InterPro.
DR   GO; GO:0019082; P:viral protein processing; IEA:InterPro.
DR   CDD; cd21512; cv_gamma-delta_Nsp2_IBV-like; 1.
DR   CDD; cd21473; cv_Nsp4_TM; 1.
DR   CDD; cd21559; gammaCoV-Nsp6; 1.
DR   CDD; cd21667; gammaCoV_Nsp5_Mpro; 1.
DR   CDD; cd21557; Macro_X_Nsp3-like; 1.
DR   Gene3D; 1.10.150.420; -; 1.
DR   Gene3D; 1.10.1840.10; -; 1.
DR   Gene3D; 1.10.8.1190; -; 1.
DR   Gene3D; 1.10.8.370; -; 1.
DR   Gene3D; 2.40.10.10; -; 2.
DR   Gene3D; 2.40.10.250; -; 1.
DR   Gene3D; 2.60.120.1680; -; 1.
DR   Gene3D; 3.30.70.3540; -; 1.
DR   Gene3D; 3.40.220.10; -; 1.
DR   InterPro; IPR043611; CoV_NSP3_C.
DR   InterPro; IPR032505; CoV_NSP4_C.
DR   InterPro; IPR043612; CoV_NSP4_N.
DR   InterPro; IPR002589; Macro_dom.
DR   InterPro; IPR043472; Macro_dom-like.
DR   InterPro; IPR044371; Macro_X_NSP3-like.
DR   InterPro; IPR036333; NSP10_sf_CoV.
DR   InterPro; IPR040795; NSP2_gammaCoV.
DR   InterPro; IPR044383; NSP2_IBV-like.
DR   InterPro; IPR044357; NSP3_Ubl1_dom_CoV.
DR   InterPro; IPR044353; Nsp3_Ubl2_dom_CoV.
DR   InterPro; IPR038123; NSP4_C_sf_CoV.
DR   InterPro; IPR044308; NSP5_Mpro_GammaCoV.
DR   InterPro; IPR043610; NSP6_CoV.
DR   InterPro; IPR044368; NSP6_gammaCoV.
DR   InterPro; IPR014828; NSP7_CoV.
DR   InterPro; IPR037204; NSP7_sf_CoV.
DR   InterPro; IPR014829; NSP8_CoV.
DR   InterPro; IPR037230; NSP8_sf_CoV.
DR   InterPro; IPR014822; NSP9_CoV.
DR   InterPro; IPR036499; NSP9_sf_CoV.
DR   InterPro; IPR013016; Peptidase_C16_CoV.
DR   InterPro; IPR008740; Peptidase_C30_CoV.
DR   InterPro; IPR043477; Peptidase_C30_dom3_CoV.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR043504; Peptidase_S1_PA_chymotrypsin.
DR   InterPro; IPR043503; PLpro_palm_finger_dom_CoV.
DR   InterPro; IPR043178; PLpro_thumb_sf_CoV.
DR   InterPro; IPR018995; RNA_synth_NSP10_CoV.
DR   Pfam; PF09401; CoV_NSP10; 1.
DR   Pfam; PF19218; CoV_NSP3_C; 1.
DR   Pfam; PF16348; CoV_NSP4_C; 1.
DR   Pfam; PF19217; CoV_NSP4_N; 1.
DR   Pfam; PF19213; CoV_NSP6; 1.
DR   Pfam; PF08716; CoV_NSP7; 1.
DR   Pfam; PF08717; CoV_NSP8; 1.
DR   Pfam; PF08710; CoV_NSP9; 1.
DR   Pfam; PF08715; CoV_peptidase; 1.
DR   Pfam; PF01661; Macro; 1.
DR   Pfam; PF17896; NSP2_gammaCoV; 1.
DR   Pfam; PF05409; Peptidase_C30; 1.
DR   SMART; SM00506; A1pp; 1.
DR   SUPFAM; SSF101816; SSF101816; 1.
DR   SUPFAM; SSF140367; SSF140367; 1.
DR   SUPFAM; SSF143076; SSF143076; 1.
DR   SUPFAM; SSF144246; SSF144246; 1.
DR   SUPFAM; SSF50494; SSF50494; 1.
DR   SUPFAM; SSF52949; SSF52949; 1.
DR   PROSITE; PS51952; COV_EXON_MTASE_COACT; 1.
DR   PROSITE; PS51992; COV_NSP3_Y3; 1.
DR   PROSITE; PS51943; COV_NSP3A_UBL; 1.
DR   PROSITE; PS51944; COV_NSP3D_UBL; 1.
DR   PROSITE; PS51946; COV_NSP4C; 1.
DR   PROSITE; PS51949; COV_NSP7; 1.
DR   PROSITE; PS51950; COV_NSP8; 1.
DR   PROSITE; PS51951; COV_NSP9_SSRNA_BD; 1.
DR   PROSITE; PS51442; M_PRO; 1.
DR   PROSITE; PS51154; MACRO; 1.
DR   PROSITE; PS51124; PEPTIDASE_C16; 1.
PE   1: Evidence at protein level;
KW   Activation of host autophagy by virus; Host cytoplasm;
KW   Host endoplasmic reticulum; Host membrane; Host-virus interaction;
KW   Hydrolase; Lyase; Membrane; Metal-binding; Protease; Reference proteome;
KW   Repeat; Ribosomal frameshifting; RNA-binding; Thiol protease;
KW   Transmembrane; Transmembrane helix; Zinc; Zinc-finger.
FT   CHAIN           1..3951
FT                   /note="Replicase polyprotein 1a"
FT                   /id="PRO_0000338314"
FT   CHAIN           1..673
FT                   /note="Non-structural protein 2"
FT                   /id="PRO_0000338315"
FT   CHAIN           674..2265
FT                   /note="Papain-like protease"
FT                   /id="PRO_0000338316"
FT   CHAIN           2266..2779
FT                   /note="Non-structural protein 4"
FT                   /id="PRO_0000338317"
FT   CHAIN           2780..3086
FT                   /note="3C-like proteinase"
FT                   /id="PRO_0000338318"
FT   CHAIN           3087..3379
FT                   /note="Non-structural protein 6"
FT                   /id="PRO_0000338319"
FT   CHAIN           3380..3462
FT                   /note="Non-structural protein 7"
FT                   /id="PRO_0000338320"
FT   CHAIN           3463..3672
FT                   /note="Non-structural protein 8"
FT                   /id="PRO_0000338321"
FT   CHAIN           3673..3783
FT                   /note="Non-structural protein 9"
FT                   /id="PRO_0000338322"
FT   CHAIN           3784..3928
FT                   /note="Non-structural protein 10"
FT                   /id="PRO_0000338323"
FT   CHAIN           3929..3951
FT                   /note="Non-structural protein 11"
FT                   /id="PRO_0000338324"
FT   TOPO_DOM        1..1750
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   TRANSMEM        1751..1771
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1772..1843
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   TRANSMEM        1844..1864
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1865..2280
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   TRANSMEM        2281..2301
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        2302..2559
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   TRANSMEM        2560..2580
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        2581..2611
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   TRANSMEM        2612..2632
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        2633..2643
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   TRANSMEM        2644..2664
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        2665..3096
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   TRANSMEM        3097..3117
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        3118..3121
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   TRANSMEM        3122..3142
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        3143..3151
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   TRANSMEM        3152..3172
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        3173..3188
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   TRANSMEM        3189..3209
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        3210..3257
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   TRANSMEM        3258..3278
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        3279..3296
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   TRANSMEM        3297..3317
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        3318..3951
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   DOMAIN          675..780
FT                   /note="Ubiquitin-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00214"
FT   DOMAIN          1003..1179
FT                   /note="Macro"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00490"
FT   DOMAIN          1175..1227
FT                   /note="Ubiquitin-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00214"
FT   DOMAIN          1236..1497
FT                   /note="Peptidase C16"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00444"
FT   DOMAIN          2161..2263
FT                   /note="CoV Nsp3 Y3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01336"
FT   DOMAIN          2684..2779
FT                   /note="Nsp4C"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01291"
FT   DOMAIN          2780..3086
FT                   /note="Peptidase C30"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00772"
FT   DOMAIN          3380..3462
FT                   /note="RdRp Nsp7 cofactor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01294"
FT   DOMAIN          3463..3672
FT                   /note="RdRp Nsp8 cofactor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01295"
FT   DOMAIN          3673..3783
FT                   /note="Nsp9 ssRNA-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01296"
FT   DOMAIN          3785..3926
FT                   /note="ExoN/MTase coactivator"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01297"
FT   ZN_FING         1353..1390
FT                   /note="C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00444"
FT   ZN_FING         3858..3878
FT                   /evidence="ECO:0000250"
FT   ZN_FING         3904..3917
FT                   /evidence="ECO:0000250"
FT   REGION          783..802
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1751..1864
FT                   /note="HD1"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   REGION          2281..2664
FT                   /note="HD2"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   REGION          3097..3317
FT                   /note="HD3"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   ACT_SITE        1274
FT                   /note="For PL-PRO activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00444"
FT   ACT_SITE        1437
FT                   /note="For PL-PRO activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00444"
FT   ACT_SITE        1448
FT                   /note="For PL-PRO activity"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6Y1"
FT   ACT_SITE        2820
FT                   /note="For 3CL-PRO activity"
FT   ACT_SITE        2922
FT                   /note="For 3CL-PRO activity"
FT   BINDING         3858
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01297"
FT   BINDING         3861
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01297"
FT   BINDING         3867
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01297"
FT   BINDING         3878
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01297"
FT   BINDING         3904
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01297"
FT   BINDING         3907
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01297"
FT   BINDING         3915
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01297"
FT   BINDING         3917
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01297"
FT   SITE            673..674
FT                   /note="Cleavage; by PL-PRO"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   SITE            2265..2266
FT                   /note="Cleavage; by PL-PRO"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   SITE            2779..2780
FT                   /note="Cleavage; by 3CL-PRO"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   SITE            3086..3087
FT                   /note="Cleavage; by 3CL-PRO"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   SITE            3379..3380
FT                   /note="Cleavage; by 3CL-PRO"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   SITE            3462..3463
FT                   /note="Cleavage; by 3CL-PRO"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   SITE            3672..3673
FT                   /note="Cleavage; by 3CL-PRO"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   SITE            3783..3784
FT                   /note="Cleavage; by 3CL-PRO"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   SITE            3928..3929
FT                   /note="Cleavage; by 3CL-PRO"
FT                   /evidence="ECO:0000250|UniProtKB:P0C6U8"
FT   VARIANT         105
FT                   /note="P -> S (in strain: Isolate Vero cell-adapted p65)"
FT   VARIANT         919
FT                   /note="K -> E (in strain: Isolate Vero cell-adapted p65)"
FT   VARIANT         932
FT                   /note="L -> I (in strain: Isolate Vero cell-adapted p65)"
FT   VARIANT         948
FT                   /note="D -> G (in strain: Isolate Vero cell-adapted p65)"
FT   VARIANT         967
FT                   /note="A -> D (in strain: Isolate Vero cell-adapted p65)"
FT   VARIANT         1133
FT                   /note="L -> S (in strain: Isolate Vero cell-adapted p65)"
FT   VARIANT         1388
FT                   /note="P -> S (in strain: Isolate Vero cell-adapted p65)"
FT   VARIANT         1753
FT                   /note="L -> F (in strain: Isolate Vero cell-adapted p65)"
FT   VARIANT         2561
FT                   /note="Q -> H (in strain: Isolate Vero cell-adapted p65)"
FT   VARIANT         3058
FT                   /note="Missing (in strain: Isolate Vero cell-adapted p65)"
FT   VARIANT         3242
FT                   /note="N -> S (in strain: Isolate Vero cell-adapted p65)"
FT   VARIANT         3409
FT                   /note="V -> A (in strain: Isolate Vero cell-adapted p65)"
FT   VARIANT         3418
FT                   /note="I -> T (in strain: Isolate Vero cell-adapted p65)"
FT   VARIANT         3471..3472
FT                   /note="IP -> MT (in strain: Isolate Vero cell-adapted p65)"
FT   VARIANT         3751
FT                   /note="V -> D (in strain: Isolate Vero cell-adapted p65)"
FT   VARIANT         3870
FT                   /note="S -> G (in strain: Isolate Vero cell-adapted p65)"
FT   VARIANT         3935
FT                   /note="D -> G (in strain: Isolate Vero cell-adapted p65)"
FT   MUTAGEN         673
FT                   /note="G->A: No processing between p87 and p195."
FT                   /evidence="ECO:0000269|PubMed:9636369"
FT   MUTAGEN         676
FT                   /note="T->S: No effect."
FT                   /evidence="ECO:0000269|PubMed:9636369"
FT   MUTAGEN         1274
FT                   /note="C->S: Complete loss of PL-PRO activity."
FT                   /evidence="ECO:0000269|PubMed:9636369"
FT   MUTAGEN         1437
FT                   /note="H->K: Complete loss of PL-PRO activity."
FT                   /evidence="ECO:0000269|PubMed:9636369"
FT   MUTAGEN         2264
FT                   /note="A->N: Almost no processing between p195 and peptide
FT                   HD2."
FT                   /evidence="ECO:0000269|PubMed:10644337"
FT   MUTAGEN         2265..2266
FT                   /note="Missing: No processing between p195 and peptide
FT                   HD2."
FT                   /evidence="ECO:0000269|PubMed:10644337"
FT   MUTAGEN         2265
FT                   /note="G->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:10644337"
FT   MUTAGEN         2265
FT                   /note="G->N: Almost no processing between p195 and peptide
FT                   HD2."
FT                   /evidence="ECO:0000269|PubMed:10644337"
FT   MUTAGEN         2266
FT                   /note="G->N: No effect."
FT                   /evidence="ECO:0000269|PubMed:10644337"
FT   MUTAGEN         2820
FT                   /note="H->K,G: Complete loss of 3CL-PRO activity."
FT                   /evidence="ECO:0000269|PubMed:7778277"
FT   MUTAGEN         2841
FT                   /note="E->Q: No effect."
FT                   /evidence="ECO:0000269|PubMed:7778277"
FT   MUTAGEN         2843
FT                   /note="E->D,N,Q: No effect."
FT                   /evidence="ECO:0000269|PubMed:7778277"
FT   MUTAGEN         2922
FT                   /note="C->A: Complete loss of 3CL-PRO activity."
FT                   /evidence="ECO:0000269|PubMed:7778277"
FT   MUTAGEN         2922
FT                   /note="C->S: Partial loss of 3CL-PRO activity."
FT                   /evidence="ECO:0000269|PubMed:7778277"
FT   MUTAGEN         3086
FT                   /note="Q->E: No processing between 3CL-PRO and p34."
FT                   /evidence="ECO:0000269|PubMed:10873746"
FT   MUTAGEN         3365
FT                   /note="Q->E: No effect."
FT                   /evidence="ECO:0000269|PubMed:10873746"
FT   MUTAGEN         3379
FT                   /note="Q->E: No processing between p34 and p9."
FT                   /evidence="ECO:0000269|PubMed:10873746"
FT   MUTAGEN         3462
FT                   /note="Q->E: No processing between p9 and p24."
FT                   /evidence="ECO:0000269|PubMed:9568037"
FT   MUTAGEN         3672
FT                   /note="Q->E: No processing between p24 and p10."
FT                   /evidence="ECO:0000269|PubMed:9032311,
FT                   ECO:0000269|PubMed:9568037"
FT   MUTAGEN         3783
FT                   /note="Q->E: No processing between p10 and p16."
FT                   /evidence="ECO:0000269|PubMed:9032311,
FT                   ECO:0000269|PubMed:9568037"
FT   MUTAGEN         3928
FT                   /note="Q->E: No processing between p16 and p100."
FT                   /evidence="ECO:0000269|PubMed:7778277"
SQ   SEQUENCE   3951 AA;  441126 MW;  9B8B2E7E2545F50C CRC64;
     MASSLKQGVS PKPRDVILVS KDIPEQLCDA LFFYTSHNPK DYADAFAVRQ KFDRSLQTGK
     QFKFETVCGL FLLKGVDKIT PGVPAKVLKA TSKLADLEDI FGVSPLARKY RELLKTACQW
     SLTVEALDVR AQTLDEIFDP TEILWLQVAA KIHVSSMAMR RLVGEVTAKV MDALGSNLSA
     LFQIVKQQIA RIFQKALAIF ENVNELPQRI AALKMAFAKC ARSITVVVVE RTLVVKEFAG
     TCLASINGAV AKFFEELPNG FMGSKIFTTL AFFKEAAVRV VENIPNAPRG TKGFEVVGNA
     KGTQVVVRGM RNDLTLLDQK ADIPVEPEGW SAILDGHLCY VFRSGDRFYA APLSGNFALS
     DVHCCERVVC LSDGVTPEIN DGLILAAIYS SFSVSELVTA LKKGEPFKFL GHKFVYAKDA
     AVSFTLAKAA TIADVLRLFQ SARVIAEDVW SSFTEKSFEF WKLAYGKVRN LEEFVKTYVC
     KAQMSIVILA AVLGEDIWHL VSQVIYKLGV LFTKVVDFCD KHWKGFCVQL KRAKLIVTET
     FCVLKGVAQH CFQLLLDAIH SLYKSFKKCA LGRIHGDLLF WKGGVHKIVQ DGDEIWFDAI
     DSVDVEDLGV VQEKSIDFEV CDDVTLPENQ PGHMVQIEDD GKNYMFFRFK KDENIYYTPM
     SQLGAINVVC KAGGKTVTFG ETTVQEIPPP DVVPIKVSIE CCGEPWNTIF KKAYKEPIEV
     DTDLTVEQLL SVIYEKMCDD LKLFPEAPEP PPFENVALVD KNGKDLDCIK SCHLIYRDYE
     SDDDIEEEDA EECDTDSGEA EECDTNSECE EEDEDTKVLA LIQDPASIKY PLPLDEDYSV
     YNGCIVHKDA LDVVNLPSGE ETFVVNNCFE GAVKPLPQKV VDVLGDWGEA VDAQEQLCQQ
     EPLQHTFEEP VENSTGSSKT MTEQVVVEDQ ELPVVEQDQD VVVYTPTDLE VAKETAEEVD
     EFILIFAVPK EEVVSQKDGA QIKQEPIQVV KPQREKKAKK FKVKPATCEK PKFLEYKTCV
     GDLTVVIAKA LDEFKEFCIV NAANEHMTHG SGVAKAIADF CGLDFVEYCE DYVKKHGPQQ
     RLVTPSFVKG IQCVNNVVGP RHGDNNLHEK LVAAYKNVLV DGVVNYVVPV LSLGIFGVDF
     KMSIDAMREA FEGCTIRVLL FSLSQEHIDY FDVTCKQKTI YLTEDGVKYR SIVLKPGDSL
     GQFGQVYAKN KIVFTADDVE DKEILYVPTT DKSILEYYGL DAQKYVIYLQ TLAQKWNVQY
     RDNFLILEWR DGNCWISSAI VLLQAAKIRF KGFLTEAWAK LLGGDPTDFV AWCYASCTAK
     VGDFSDANWL LANLAEHFDA DYTNAFLKKR VSCNCGIKSY ELRGLEACIQ PVRATNLLHF
     KTQYSNCPTC GANNTDEVIE ASLPYLLLFA TDGPATVDCD EDAVGTVVFV GSTNSGHCYT
     QAAGQAFDNL AKDRKFGKKS PYITAMYTRF AFKNETSLPV AKQSKGKSKS VKEDVSNLAT
     SSKASFDNLT DFEQWYDSNI YESLKVQESP DNFDKYVSFT TKEDSKLPLT LKVRGIKSVV
     DFRSKDGFIY KLTPDTDENS KAPVYYPVLD AISLKAIWVE GNANFVVGHP NYYSKSLHIP
     TFWENAENFV KMGDKIGGVT MGLWRAEHLN KPNLERIFNI AKKAIVGSSV VTTQCGKLIG
     KAATFIADKV GGGVVRNITD SIKGLCGITR GHFERKMSPQ FLKTLMFFLF YFLKASVKSV
     VASYKTVLCK VVLATLLIVW FVYTSNPVMF TGIRVLDFLF EGSLCGPYKD YGKDSFDVLR
     YCADDFICRV CLHDKDSLHL YKHAYSVEQV YKDAASGFIF NWNWLYLVFL ILFVKPVAGF
     VIICYCVKYL VLNSTVLQTG VCFLDWFVQT VFSHFNFMGA GFYFWLFYKI YIQVHHILYC
     KDVTCEVCKR VARSNRQEVS VVVGGRKQIV HVYTNSGYNF CKRHNWYCRN CDDYGHQNTF
     MSPEVAGELS EKLKRHVKPT AYAYHVVDEA CLVDDFVNLK YKAATPGKDS ASSAVKCFSV
     TDFLKKAVFL KEALKCEQIS NDGFIVCNTQ SAHALEEAKN AAIYYAQYLC KPILILDQAL
     YEQLVVEPVS KSVIDKVCSI LSSIISVDTA ALNYKAGTLR DALLSITKDE EAVDMAIFCH
     NHDVDYTGDG FTNVIPSYGI DTGKLTPRDR GFLINADASI ANLRVKNAPP VVWKFSELIK
     LSDSCLKYLI SATVKSGVRF FITKSGAKQV IACHTQKLLV EKKAGGIVSG TFKCFKSYFK
     WLLIFYILFT ACCSGYYYME VSKSFVHPMY DVNSTLHVEG FKVIDKGVLR EIVPEDTCFS
     NKFVNFDAFW GRPYDNSRNC PIVTAVIDGD GTVATGVPGF VSWVMDGVMF IHMTQTERKP
     WYIPTWFNRE IVGYTQDSII TEGSFYTSIA LFSARCLYLT ASNTPQLYCF NGDNDAPGAL
     PFGSIIPHRV YFQPNGVRLI VPQQILHTPY VVKFVSDSYC RGSVCEYTRP GYCVSLNPQW
     VLFNDEYTSK PGVFCGSTVR ELMFSMVSTF FTGVNPNIYM QLATMFLILV VVVLIFAMVI
     KFQGVFKAYA TTVFITMLVW VINAFILCVH SYNSVLAVIL LVLYCYASLV TSRNTVIIMH
     CWLVFTFGLI VPTWLACCYL GFIIYMYTPL FLWCYGTTKN TRKLYDGNEF VGNYDLAAKS
     TFVIRGSEFV KLTNEIGDKF EAYLSAYARL KYYSGTGSEQ DYLQACRAWL AYALDQYRNS
     GVEIVYTPPR YSIGVSRLQS GFKKLVSPSS AVEKCIVSVS YRGNNLNGLW LGDTIYCPRH
     VLGKFSGDQW NDVLNLANNH EFEVTTQHGV TLNVVSRRLK GAVLILQTAV ANAETPKYKF
     IKANCGDSFT IACAYGGTVV GLYPVTMRSN GTIRASFLAG ACGSVGFNIE KGVVNFFYMH
     HLELPNALHT GTDLMGEFYG GYVDEEVAQR VPPDNLVTNN IVAWLYAAII SVKESSFSLP
     KWLESTTVSV DDYNKWAGDN GFTPFSTSTA ITKLSAITGV DVCKLLRTIM VKNSQWGGDP
     ILGQYNFEDE LTPESVFNQI GGVRLQSSFV RKATSWFWSR CVLACFLFVL CAIVLFTAVP
     LKFYVYAAVI LLMAVLFISF TVKHVMAYMD TFLLPTLITV IIGVCAEVPF IYNTLISQVV
     IFLSQWYDPV VFDTMVPWMF LPLVLYTAFK CVQGCYMNSF NTSLLMLYQF VKLGFVIYTS
     SNTLTAYTEG NWELFFELVH TTVLANVSSN SLIGLFVFKC AKWMLYYCNA TYLNNYVLMA
     VMVNCIGWLC TCYFGLYWWV NKVFGLTLGK YNFKVSVDQY RYMCLHKINP PKTVWEVFST
     NILIQGIGGD RVLPIATVQA KLSDVKCTTV VLMQLLTKLN VEANSKMHVY LVELHNKILA
     SDDVGECMDN LLGMLITLFC IDSTIDLSEY CDDILKRSTV LQSVTQEFSH IPSYAEYERA
     KNLYEKVLVD SKNGGVTQQE LAAYRKAANI AKSVFDRDLA VQKKLDSMAE RAMTTMYKEA
     RVTDRRAKLV SSLHALLFSM LKKIDSEKLN VLFDQASSGV VPLATVPIVC SNKLTLVIPD
     PETWVKCVEG VHVTYSTVVW NIDTVIDADG TELHPTSTGS GLTYCISGAN IAWPLKVNLT
     RNGHNKVDVV LQNNELMPHG VKTKACVAGV DQAHCSVESK CYYTNISGNS VVAAITSSNP
     NLKVASFLNE AGNQIYVDLD PPCKFGMKVG VKVEVVYLYF IKNTRSIVRG MVLGAISNVV
     VLQSKGHETE EVDAVGILSL CSFAVDPADT YCKYVAAGNQ PLGNCVKMLT VHNGSGFAIT
     SKPSPTPDQD SYGGASVCLY CRAHIAHPGS VGNLDGRCQF KGSFVQIPTT EKDPVGFCLR
     NKVCTVCQCW IGYGCQCDSL RQPKSSVQSV AGASDFDKNY LNGYGVAVRL G
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024